RxDoctor Payments Data

Danish Zaidi, MD

Interventional Pain Medicine · North Kansas City, MONPI 1053846386

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 97.8% of the total across 115 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 5 manufacturers reported payments, led by Medtronic at 55.3% of the total. Reporting peaked in 2022 at $1,006 and has fallen 78.6% since, to $215 in 2025. That places this record below the midpoint for interventional pain medicine clinicians in MO, where the typical reported total is $2,673.

$2,360in general payments, 2019–2025

Across 115 payments — averaging $20.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$1K
  • Boston Scientific$449
  • Nevro Corp.$274
  • SPR Therapeutics, Inc$271
  • Stryker$60

What the payments were for

  • Travel & lodging$522%
  • Food & beverage$2,30898%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Medtronic101$1,305
Boston Scientific3$449
Nevro Corp.3$274
SPR Therapeutics, Inc6$271
Stryker2$60

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,360 in reported general payments places this provider in the 40th percentile of 27 interventional pain medicine providers in Missouri.

See all interventional pain medicine providers in Missouri

Medicare billing

Part B allowed, 2024
$186,916
Medicare patients
401
Services billed
1,806

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen184$3,529
Gabapentin146$1,847
Pregabalin63$1,321
Tizanidine Hcl74$840
Oxycodone Hcl47$770
Diclofenac Sodium61$667
Tramadol Hcl-AcetaminophenTramadol Hcl/Acetaminophen75$633
Tramadol Hcl79$455
Baclofen32$442
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen15$356
Methylprednisolone54$298
Celecoxib19$215
Lorazepam34$18

Paid to pharmacies, not to this prescriber.

Other interventional pain medicine in North Kansas City

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →